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Maternal Zika virus (ZIKV) infection during pregnancy is recog-
nized as the cause of an epidemic of microcephaly and other
neurological anomalies in human fetuses. It remains unclear how
ZIKV accesses the highly vulnerable population of neural progen-
itors of the fetal central nervous system (CNS), and which cell
types of the CNS may be viral reservoirs. In contrast, the related
dengue virus (DENV) does not elicit teratogenicity. To model viral
interaction with cells of the fetal CNS in vitro, we investigated the
tropism of ZIKV and DENV for different induced pluripotent stem
cell-derived human cells, with a particular focus on microglia-like
cells. We show that ZIKV infected isogenic neural progenitors,
astrocytes, and microglia-like cells (pMGLs), but was only cytotoxic
to neural progenitors. Infected glial cells propagated ZIKV and
maintained ZIKV load over time, leading to viral spread to suscep-
tible cells. DENV triggered stronger immune responses and could
be cleared by neural and glial cells more efficiently. pMGLs, when
cocultured with neural spheroids, invaded the tissue and, when
infected with ZIKV, initiated neural infection. Since microglia
derive from primitive macrophages originating in proximity to the
maternal vasculature, they may act as a viral reservoir for ZIKV and
establish infection of the fetal brain. Infection of immature neural
stem cells by invading microglia may occur in the early stages of
pregnancy, before angiogenesis in the brain rudiments. Our data are
also consistent with ZIKV and DENV affecting the integrity of the
blood–brain barrier, thus allowing infection of the brain later in life.
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Zika virus (ZIKV) emerged in 1947, and had not been con-sidered a grave threat to humans until very recently (1). In
2013, an epidemic in French Polynesia was associated with sig-
nificant morbidity in the form of Guillain-Barre syndrome (2).
Since 2014, the virus has been spreading throughout the Amer-
icas and the Caribbean, threatening the southern United States
where populations of its mosquito vectors, Aedes aegyptii and
Aedes albopictus, are endemic. Concurrent to the spread of
ZIKV in South America, a rise in cases of severe fetal malfor-
mations, including microcephaly (3, 4), was rapidly linked to
maternal infection, with apparent peak vulnerability during the
first trimester of pregnancy (3, 5). While neural progenitor cells
(NPCs) have been shown to be highly sensitive to infection (6–9),
the current epidemic raises many questions. Why is ZIKV pre-
senting so severely and only now? Sequence variations (10) be-
tween the original 1947 Ugandan strain (ZIKVu) and the current
circulating variants are relatively minor, although recent analysis
indicates the presence of a novel mutation in the prM protein
associated with the currently circulating American strains (11).
How does ZIKV accomplish its vertical transmission from
mother to fetus despite all defenses in place? The damage to the
fetus can be quite variable, possibly pointing to narrow windows
of opportunity for the virus to wreak havoc on development.
What makes human hosts so vulnerable, when mice do not de-
velop the disease unless their antiviral defenses are knocked
down (12–14)? This latter consideration questions our ability to
model the pathology in rodents, as the needs to dampen in-
terferon (IFN) responses make the study of viral spread within
the mouse host arduous. What of the vulnerability of more ma-
ture nervous systems: Can the virus be completely cleared post-
natally, or does it leave neurological sequalae even in absence of
overt teratogenicity? Are there circumstances in which ZIKV can
reach an adult nervous system from the periphery (2, 15)? The
consequence of such an event are largely unknown.
Significance
We describe the ability of the Zika virus to infect various cells
of the fetal brain, modeled from induced pluripotent stem cells
derived from a patient and grown in identical conditions. Zika
is associated with microcephaly, while the similar dengue virus
is not. We described differences in the behavior of these two
viruses. Zika often fails to trigger efficient antiviral responses,
surviving encounters with brain immune cells, and killing im-
mature nerve cell precursors that have poor innate antiviral
defenses. Precursors of the brain’s immune cells, microglia,
circulating in the fetus, may take the virus to the fetal brain
where it will stall growth or cause cell death. We show that
interferon-γ efficiently protects against this viral transfer.
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In this report, we address some of these questions using
in vitro modeling to study the interaction of ZIKV with various
cells of the CNS. We focused our study on the prototypical
ZIKVu strain, which is well characterized and particularly cyto-
toxic in vitro (7). We contrast the tropism and cytotoxicity of
ZIKV with that of dengue (DENV), a closely related flavivirus
(16), for which there are no known reports of teratogenic events.
DENV may in some circumstances prove neurotropic and neu-
rovirulent, but the incidence of such pathology is limited. DENV
is carried by the same mosquito vectors and is therefore present
in overlapping geographic areas. Until the current reemergence
of ZIKV, DENV was the most concerning arbovirus in the de-
veloping world. De facto, we have much to glean from under-
standing the differences and similarities between these viruses to
therapeutic discovery. The interactions between DENV and
ZIKV may be particularly relevant, as many patients contracting
ZIKV have already been exposed to DENV.
Results
We generated multiple cell types from human induced pluripo-
tent stem (iPS) cells, allowing derivation from a given donor (17,
18), avoiding confounding effects of genetic background on viral
infectivity or cytotoxicity. Microglia, neural progenitors, astro-
cytes, and neurons, the four CNS cell types used in our study,
were derived from the same iPS cells and grown in a common
serum-free medium. The cells were infected with the MR766
strain of ZIKVu, which has been reported to be cytotoxic to
human neural progenitors (7, 8). We confirmed that a ZIKVu
inoculum corresponding to a multiplicity of infection (MOI) of 1
(as measured independently on Vero cells) was highly infective
and cytotoxic to iPS-derived neural progenitors (Fig. 1A, Left
and SI Appendix, Fig. S1). The cells accumulated large envelope-
positive cytoplasmic inclusions and died by caspase-mediated
apoptosis (SI Appendix, Fig. S1). When challenged with in-
creasing multiplicities of ZIKVu, NPCs accumulated viral ge-
nome (vRNA) up to twice the levels of endogenous GAPDH
(Fig. 1B, Left). When infecting astrocytes, differentiated from
NPCs, cells became positive for the ZIKV envelope protein (Fig.
1A,Middle) and produced vRNA in excess of endogenous GAPDH
(Fig. 1B, Middle), but virus-induced cell death was not observed (SI
Appendix, Fig. S1). iPS-derived microglia-like cells (pMGLs) in-
fected with ZIKVu became positive for the ZIKV envelope protein
(Fig. 1A, Right) and accumulated vRNA in a dose-dependent man-
ner reaching levels of almost 50% of GAPDH expression (Fig. 1B,
Right); however, virus-induced cell death was not detected (SI Ap-
pendix, Fig. S1). As shown in Fig. 1C, all cells produced detectable
levels of vRNA after 24 h, with NPCs producing more viral ge-
nomes than pMGLs, consistent with the envelope staining.
DENV, a flavivirus closely related to ZIKV, is transmitted by
the same mosquito vectors but is not known to be overtly tera-
togenic, although there are indications that it can be neurotropic
and neurovirulent (19). To define the different pathogenicity of
these related viruses we exposed the same cell types to DENV2.
Fig. 1D shows that, while the virus infected and replicated in all
cell types, the maximum DENV2 vRNA levels at 24 h were
generally lower than those of ZIKV in the same cells, except in
pMGLs where they reached 17% of GAPDH. To assess the ki-
netics of virus replication, we compared ZIKVu and DENV2
vRNA levels at different times after infection. As shown in Fig.
1E, ZIKVu vRNA levels changed rapidly from 24 to 72 h after
infection, increasing 30-fold in NPCs (Left), 13-fold in astrocytes
(Middle), and 9-fold more in pMGLs (Right). In contrast,
DENV2 vRNA levels were lower at 24 h and appeared to de-
crease over the next 2 d (Fig. 1F). These results suggest that
these cell types limit infection and replication of DENV2, while
ZIKVu replication is exponential during this time.
The results in Fig. 1 E and F suggest that antiviral responses
to infection are different for each virus, limiting DENV2 but
allowing ZIKVu amplification. We assessed the effect of IFN
pathways stimulation and inhibition on viral accumulation.
When B18R, an inhibitor of type I IFN sensing and signaling,
was added to infected cultures, ZIKVu replication was signifi-
cantly increased after infection of astrocytes and microglia, and
more marginally in NPCs (Fig. 2A). Conversely, when infected
cultures were exposed to recombinant IFN-γ as an agonist of the
type II IFN pathway, virus production was inhibited in all three
cell types (Fig. 2A). In striking contrast, DENV2 did not increase
in response to B18R, and was not inhibited by IFN-γ in any of
the cell types (Fig. 2B). As shown in SI Appendix, Fig. S2, IFN-γ
treatment of ZIKVu-infected NPCs efficiently protected these
cells from infection and cell death.
To investigate whether the two viruses elicit different antiviral
responses in infected cells, we measured gene expression of ca-
nonical viral sensors and downstream IFN-stimulated genes
(ISGs). RIG-I is a dsRNA helicase acting as a primary sensor of
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Fig. 1. ZIKV and DENV display different tropism and kinetics. (A, Left)
Sox2+ (green, nuclear) iPS-derived NPCs infected with ZIKV (red, envelope
staining). (Scale bar, 40 μm.) (Middle) GFAP+ (green, cytoplasmic) iPS-derived
astrocytes derived from the same parental line display cytoplasmic ZIKV in-
clusions (red, envelope staining). (Scale bar, 40 μm.) (Right) PU.1+ microglia
(green, nuclear) derived from the same parental line, also got infected with
ZIKV and display numerous cytoplasmic foci positive for ZIKV envelope (red
channel). (Scale bar, 12 μm.) (B) Dose-dependent infection of different cell
types with ZIKVu. qPCR of ZIKV RNA (normalized to GAPDH) as a function of
input inoculum MOI (Left, NPCs; Middle, astrocytes; Right, pMGLs). n = 4
technical replicates. (C) qPCR of ZIKV RNA at 24 h after infection of indicated
cell types with inoculum (MOI 1), normalized to GAPDH. n = 2 technical
replicates. (D) qPCR of DENV RNA at 24 h after infection of indicated cell
types with viral inoculum (MOI 1), normalized to GAPDH. n = 2 technical
replicates. *P < 0.0001 for ANOVA with post hoc Tukey test. (E) Kinetics of viral
RNA accumulation (as percentage of GAPDH) between 24 h and 72 h post-
infection (hpi) with ZIKV inoculum (MOI 1) in isogenic NPCs (Left), astrocytes
(Middle), and pMGLs (Right). *P < 0.05 for unpaired two-tailed t test. (F) Kinetics
of viral restriction between 24 h and 72 h postinfectionwith DENV inoculum (MOI
1) in isogenic NPCs (Left), astrocytes (Middle), and pMGLs (Right). *P < 0.05 for
unpaired two-tailed t test. (B–F) Error bars are mean ± SD (technical replicates).
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invasion by multiple viruses (20), including DENV and other
flaviviruses. OAS2 is an IFN-inducible enzyme which, in the
presence of dsRNA, synthesizes an activator of RNase L acting
as an effector of viral genome degradation and replication in-
hibition (21). Fig. 2C shows that RIG-I was induced within 24 h
of exposure to DENV2 (blue data points in each graph) relative
to control (black data points) in NPCs (Left), astrocytes (Middle),
and microglia (Right), but RIG-I levels remained very low in both
astrocytes and NPCs when exposed to ZIKVu (red data points)
at a MOI that resulted in robust viral infection and replication
and caused death of NPCs. Interestingly, ZIKVu triggered RIG-I
up-regulation in pMGLs, likely owing to the specialized role of
these cells as innate immune effectors. Similarly, OAS2 was
induced in all three cell types by exposure to DENV2 (Fig. 2D)
and in pMGLs only by ZIKVu.
To assess more broadly the baseline antiviral capabilities of
the different cell types, we measured expression of RIG-I,
MDA5, OAS2, andMX1 in absence of infection. As shown in Fig.
3A, NPCs had the lowest average levels of expression of these
antiviral response genes, while pMGLs displayed the highest
average. Fig. 3B shows that, in contrast to pMGLs exposed to
ZIKVu, pMGLs exposed to DENV2 (middle blot) expressed and
secreted cytokines and chemokines whose combined action
could be further involved in neuroinflammatory processes (such
as CXCL10, see blot map in Fig. 3C) and elicit cytotoxic effects
to defend the host. We observed that these early differences
in cytokine release are not accompanied by a delayed rise in
CXCL10 or IL6 transcription after ZIKA infection, but rather an
apparent resolution (SI Appendix, Fig. S3) in both cases.
To understand virus pathogenesis, it is crucial to define the
cell type that initiates and propagates virus in the fetus after
primary infection of the mother. As a surrogate for virus pro-
duction, we tested the supernatant of infected pMGLs, astro-
cytes, and NPCs for the presence of vRNA. As shown in Fig. 4A,
the supernatants of pMGLs, astrocytes, and NPCs infected with
either DENV2 or ZIKVu contained vRNA after 72 h, consistent
with virus shedding and with ZIKVu-infected NPCs producing
high levels before death. Remarkably, we observed that DENV2
was cytotoxic to pMGLs, in contrast to ZIKVu, which did not
induce cell number loss within 3 d of infection (Fig. 4B) but rather
allowed release of viral genomes more than a week after initial
infection (Fig. 4C). Large concentrations of ZIKVu vRNA could
be detected more than a week after initial infection of astrocytes,
while DENV2 genome release was significantly lower (Fig. 4D).
To test for the presence of active virus, beyond the vRNA
presence, we exposed IFN-deficient Vero cells to the superna-
tant of the infected human cells. Fig. 4E shows that the super-
natant from ZIKVu-infected microglia was efficient in establishing
infection of Vero cells, as was the supernatant from infected
NPCs. When neural progenitors, thought to represent the most
relevant target cells for teratogenesis, were exposed to the
supernatants of infected microglia, they became homogenously
positive for ZIKV envelope protein (Fig. 4F) consistent with the
possibility that primitive macrophages and microglia could initiate
infection of the fetal brain.
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Fig. 2. Different IFN responses to ZIKV and DENV infection. (A) At 72 h
postinfection, type I IFN inhibition by B18R increased ZIKV load (Middle)
compared with control infection, while type II IFN activation by IFN-γ (Right)
decreased ZIKV load (normalized to control ZIKV infection, Left and dashed
line at 1), in isogenic NPCs (Left), astrocytes (Middle), and pMGLs (Right). n =
4 technical replicates. *P < 0.05 for ANOVA with post hoc Tukey test. (B)
Effect of type I IFN inhibition (B18R,Middle) and type II IFN activation (IFN-γ,
Right) on DENV viral load (normalized to control DENV infection, Left and
dashed line at 1) in isogenic NPCs (Left), astrocytes (Middle), and pMGLs
(Right). n = 2 technical replicates. (C and D) qPCR for the viral sensor RIG-I
(C) and effector OAS2 (D) following infection with DENV and ZIKV in iso-
genic NPCs (Left, n = 6), astrocytes (Middle, n = 6), and pMGLs (Right, n = 4).
RIG-I and OAS2 are significantly induced by DENV in all cells, and by ZIKV
only in pMGLs. Gene expression is quantified 24 h postinfection and
expressed normalized to GAPDH. Error bars are mean ± SD. *P < 0.05 for
ANOVA with post hoc Tukey test.
RIG-I MDA5 OAS2 MX1 score 
NPCs 0.12 0.06 0.01 0.10 0.07 
Astrocytes 0.90 0.60 0.30 0.70 0.63 
Fibroblasts 1.70 1.50 1.60 1.80 1.65 
pMGLs 1.20 7.00 1.30 3.90 3.35 
REF C5 CD40L GCSF GMCSF CXCL1 CCL1 CD54 IFNg REF 
IL1a IL1b IL1ra IL2 IL4 IL5 IL6 IL8 
IL10 IL12 IL13 IL16 IL17 IL17e IL23 IL27 
IL32a CXCL10 CXCL11 CCL2 MIF CCL3 CCL4 PAI-1 
REF CCL5 CXCL12 TNFa TREM1 
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Fig. 3. (A) Expression levels (qPCR) of a panel of four main effectors of IFN
signaling (RIG-I, MDA5, OAS2, and MX1) and their averages in four relevant
cell types (NPCs, astrocytes, pMGLs, and human skin fibroblasts). Color
ranges from red (0% GAPDH) to green (7% GAPDH). We measured the av-
erage of these four genes, as an IFN-defense score. NPCS have very low basal
mean expression of all four genes (average 0.07), while pMGLs have high
basal mean expression (average 3.35). (B) Cytokine profiles of microglia in-
fected with ZIKV and DENV (medium conditioned from 12 hpi to 24 hpi).
DENV induced the release of cytokines/chemokines typical of macrophage
activation (CCL5, C5, and CXCL10). In contrast, ZIKV elicited the release of
fewer cytokines/chemokines (CCL2 and IL8). (C) Map of cytokines and che-
mokines array probed in B, equivalent to the dashed white lines.
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To model the ability of infected microglial precursors (primi-
tive macrophages) to migrate into the developing CNS and
spread ZIKV to vulnerable cells, we developed a 3D-culture
model expanding on our initial work replicating an organotypic
environment for microglia (18, 22, 23). Fig. 4G shows that im-
mature GFP-labeled pMGLs, paired with a neuralized organoid,
actively migrate into the growing tissue, taking residence and
eventually adopting the ramified morphology of more mature
microglial cells (Fig. 4H). When pMGLs that were preinfected
with ZIKVu were cocultured with uninfected organoids (Fig. 4I,
Right), we found that invading pMGLs penetrated the tissue and
could be detected below the surface of the neural tissue as large
amoeboid cells filled with granular phagocytic content, positive
for Iba1, and reminiscent of the Gitter cell endpoint of microglia
(24). Surrounding the invading pMGLs (red channel), we ob-
served a zone of loose cellular structure displaying elevated
ZIKV envelope signal interspersed with pyknotic and frag-
mented nuclei, indicative of an ongoing degenerative process
(green, dashed loop). For reference, we verified that direct in-
fection with a ZIKV inoculum of a similar-sized organoid,
resulted in stalled growth (SI Appendix, Fig. S4A), as previously
reported (25, 26). Fig. 4J depicts the increase in viral load in the
target organoid, in the days following pairing with infected
pMGLs. Higher magnification of organoid sections showed that
the ZIKV-positive microglial cells initiated infection of adjacent
cells, as exemplified by the large ZIKV-positive cytoplasmic in-
clusions found in nearby parenchymal cells (SI Appendix, Fig.
S4B, Right, yellow arrowheads, all panels).
Astrocytes are, in intimate partnership with endothelial cells,
the primary components of the blood–brain barrier (BBB) de-
fining the specialized immune environment of the CNS (27),
preventing entry of pathogens and immune cells. We compared
viral cytotoxicity to astrocytes and endothelial cells, exposing
homogenous cultures to ZIKVu and DENV2. As shown in Fig.
5A, Middle DENV2 exposure was cytotoxic to astrocytes, de-
creasing density, and rapidly (<24 h) triggered apoptotic cell
death (SI Appendix, Fig. S5). In contrast, ZIKVu only caused an
increase in GFAP staining (Fig. 5A, Right), characteristic of
astrogliosis (28) without changes in cell density (SI Appendix, Fig.
S5). Endothelial cells infected with DENV2 or ZIKVu (Fig. 5B)
displayed faint and fragmented ZO-1 staining, indicating a
disruption of tight junctions’ continuity, which is essential to the
endothelial barrier role. This disruption may be relevant to the
consequences of postnatal infections, including infections in
the adult human. Indeed, as shown in Fig. 5C, neuronal cultures
could be efficiently infected with ZIKV in a dose-dependent
manner. To assess whether virus infection could cause func-
tional impairment, we infected cultures grown on multielectrode
arrays. As shown in Fig. 5 D and E, infections with DENV2 or
ZIKVu induced a rapid loss of electrophysiological activity.
Strikingly, DENV2-infected neurons recovered, and resumed
activity spontaneously (Fig. 5E), indicating that DENV2 can
be neurotoxic, but functional impairment is reversible at the
cellular level. In the tested conditions of infection, ZIKV-
infected neurons did not recover, eventually degenerating (SI
Appendix, Fig. S6).
Discussion
As is the case with DENV infection, ZIKV has been known to
result in a self-limiting and mild disease in most adult patients,
with rashes and fevers being the most common symptoms (29).
While DENV sometimes leads to a grave hemorrhagic syndrome
(16, 30), and in rare cases to neurological damage, maternal
ZIKV infection during early stages of pregnancy can often result
in fetal neurological abnormalities, ranging from inflammatory
scarring with calcifications to severe microcephaly at birth (3,
31). It is currently unknown how ZIKV crosses all maternal–fetal
defenses and barriers to reach the fetal CNS, why virus infection
during the first trimester is most damaging (5), or why the closely
related flavivirus DENV does not cause fetal brain injury. Al-
though great success has already come from the study of ZIKV
in pluripotent stem cell-derived cultures (6–9, 32), both viruses
are difficult to model in mice, unless IFN defenses are ubiqui-
tously ablated (33, 34). Here we show that ZIKVu is under
tighter IFN restriction than DENV2 in all studied cells (Fig. 2),
and that cells which are highly vulnerable, such as neural pro-
genitors, have low baseline defenses (Fig. 3) and are unable to
mount an efficient response before viremia slows growth or
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Fig. 4. Glial cells can infect neural progenitors. (A)
Viral RNA was present in the supernatant of micro-
glia, astrocytes, and NPCs 72 h postinfection. n = 2 or
3 technical replicates. (B) ZIKV-infected microglia
survive infection, while the viability of DENV-
infected microglia was compromised after 72 h, in
a dose-dependent manner (n = 1 observation per
condition). (C and D) Viral RNA was present in the
conditioned medium 10 d after infection of microglia
(C) and 9 d after infection of astrocytes (D). ZIKV-
infected cells, particularly microglia, maintained
higher levels (4 logs) than cells infected with DENV.
n = 2 technical replicates. (E) Viral RNA corresponded
to infectious viral particles, as measured by re-
infection of IFN-deficient Vero cells by conditioned
medium from indicated cell types (n = 1, square:
MOI = 1; round: MOI = 5). (F) Supernatants from
infected microglia efficiently triggered production of
ZIKV envelope proteins (green channel) in a lawn of
neural progenitors (magenta, nuclear DAPI). (Scale
bar, 80 μm.) (G) Uninfected microglia (GFP labeled)
cocultured in suspension with cerebral organoids
(spheroids 14 d after reaggregation of NPCs) invaded
and scattered in the tissue. (Scale bar, 200 μm.) (H)
Uninfected resident microglia adopt ramified mor-
phologies typical of more mature cells. (Scale bars, 10 μm.) (I) Section of uninfected organoid showing background fluorescence in absence of virus (Left).
When cocultured with ZIKV-infected microglia (red channel), ZIKV-positive signal spreads through the organoid (dashed area), surrounding the invading cells
(Right). (J) qPCR of ZIKVu viral amounts normalized to GAPDH, in neural organoids paired with infected microglia at t = 0 h. ZIKV is amplified exponentially in
the target organoid. Error bars represent mean ± SD (n = 2 technical replicates).
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triggers death. We also show that microglia-like cells can be
productively infected and show little cytotoxicity (Figs. 1–3
and SI Appendix, Fig. S1), even when infected with high titers
of ZIKV. In contrast, DENV triggers cytotoxic reactions in
microglia-like cells, as has been reported for other myeloid
cells (35).
Our results suggest that DENV can be efficiently restricted by
the IFN responses it triggers: this suggests it may more rarely
reach distant tissue (host brain, fetal brain). In the fetus, prim-
itive macrophages/immature microglia, would make poor vectors
for DENV, as these cells are highly vulnerable to DENV in-
fection. In contrast, ZIKV may have evolved an optimal set of
characteristics, allowing it to replicate and propagate in myeloid
cells, culminating in infection of microglial precursors without
causing serious cytotoxic effects, giving them time to propagate
the virus to the tissues they encounter. At the maternal–fetal
boundary, cytotrophoblast cells and Hofbauer cells, residing in
the chorionic villi, can be infected by ZIKV (36, 37). ZIKV can
reach these cells through the chorioallantoic placenta or the
highly vascularized yolk sac splanchnopleure. Our work suggests
that microglial precursors migrating between the blood islands of
the yolk sac (where they originate) and the embryo proper may
represent attractive candidate cells that are susceptible to in-
fection, able to transport the virus to the CNS, and mediate in-
fection of neural progenitors (Fig. 6).
Timing of infection into microglial precursors migrating to the
CNS, before closure of the BBB, may be among the mechanisms
enhancing teratogenicity in the first trimester. In vivo evidence of
such an event is not currently available, although microglia have
been shown to be susceptible to infection in several models, in-
cluding fetal human slice cultures (38), human fetal brain
preparations (39), and nonhuman primates (40). The general
reliance of mouse models on blunted IFN defenses to observe
any pathogenicity of ZIKV hinders direct assessment of this
transfer hypothesis. However, striking circumstantial support can
be found in a recent study (41) using immunocompetent mice,
bypassing most of the host defenses using intrauterine injections
of the virus. In this study, the authors showed that ZIKV, in-
jected at embryonic day 10 (E10), could later be found in the
fetal mouse brain, more specifically in microglia where it trig-
gered their activation. Remarkably, when injection was per-
formed later, at E14, the virus failed to reach the fetal CNS. It
should be noted that at E10, yolk sac microglial precursors are
entering the CNS, while at E14, this emigration is complete (42).
We note that pMGLs, in contrast to NPCs, can still mount a
response to the virus: in certain circumstances they may help
limit viral spread in the CNS parenchyma, for example, at later
stages when more mature and present at higher density. A study
published while this manuscript was under review (43), sup-
porting many of our own findings, suggest this may indeed be the
case: cocultures of NPCs and iPS-derived macrophages demon-
strated less viral positivity than NPCs alone after exposure to
ZIKV. The authors concluded there was active removal of in-
fected NPCs by macrophages, highlighting the complex interplay
between their role as vectors and as protective actors.
AXL is an attractive candidate receptor for the virus (44, 45),
although AXL ablation was recently found to have no effect on
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Fig. 5. Modeling the postnatal effects of CNS infection. (A) Astrocytes
responded differently to DENV and ZIKV challenges. DENV promoted a loss
of viability (Middle, DAPI staining), and an overall decrease of GFAP staining
(Middle, green channel). In contrast, ZIKV did not alter cell numbers (Right),
but triggered a relative increase in GFAP staining intensity, characteristic of
astrogliosis. (Scale bar, 40 μm.) (B) Blood–brain barrier modeled with a
confluent culture of iPS-derived endothelial cells, forming a network of ZO-1
positive tight junctions (green channel, Left). Both DENV (Middle) and ZIKV
(Right) elicited a loss of ZO-1 staining intensity. (Scale bar, 40 μm.) (C) A
mixed culture of neurons differentiated for 4 wk could be efficiently in-
fected by ZIKV, in an input MOI-dependent manner (ZIKV RNA normalized
to GAPDH) (n = 2 technical replicates). (D) Neuronal culture, infected with
ZIKV at electrophysiological maturity (6 wk, day 0 of x axis), displayed a rapid
and irreversible drop in action potential firing rate (red trace) compared
with control (black trace). (E) In contrast, DENV infection resulted in a re-
versible loss of spontaneous electrical activity (blue trace), reverting to
control levels of activity (black trace) after 2 wk. (D and E) Values are mean ±
SEM (n = 5 technical replicates for controls, 3 for ZIKVu, 2 for DENV).
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Fig. 6. Diagram of the proposed maternal–fetal myeloid chain of ZIKV
transmission, from skin macrophages (Langerhans and dendritic cells) all the
way to the fetus. Virus from pools of infected decidual maternal macro-
phages break through placental defenses. Placental fetal resident macro-
phages get infected but do not travel or come in physical contact with the
fetal CNS. Microglial precursors, migrating past the placental and vitelline
exchange endothelia, get infected on their way to the embryo, invading the
neural tube at its most vulnerable stage. Migration eventually stops, and the
blood–brain barrier closes. ZIKV-infected immune cells may constitute a viral
reservoir for sustained periods. In contrast, DENV may never reach the fetal
neighborhoods, actively restricted in the maternal host, or triggering cell
death in microglia precursors it reaches.
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the behavior of ZIKV toward neural progenitors (46), and AXL
is dispensable for infection in the mouse (34). Other entry
mechanisms active in myeloid cells such as microglia include Fc
receptors that may allow enhanced endocytosis of virions in the
presence of antibodies with partial avidity for ZIKV (1, 47–49).
An interesting implication would be that cross-reactive maternal
antibodies, some of which may come from previous DENV in-
fections and are present in the fetus, will favor viral infection of
primitive myeloid cells such as microglia, further enhancing de-
livery to the fetal brain (47–49). In the adult, prior DENV in-
fections may leave the BBB vulnerable while also enhancing
ZIKV infectivity. We show that DENV2 and ZIKVu may alter
the integrity of elements of the BBB, disturbing tight junctions
between endothelial cells. Interestingly, it was recently observed
that ZIKV protein NS2A can disrupt adherent junctions in radial
glial cells (6). We also show ZIKV can activate astrocytes, while
DENV2 is actively cytotoxic. Finally, we observed that ZIKV can
permanently damage electrophysiologically active neuronal net-
works, consistent with viral toxicity in the adult (2), which may be
aggravated in cases of coinfection. Ultimately, astrocytes and
microglia may become long-term viral reservoirs in the absence
of efficient clearing mechanisms, and the consequences of such
events remain to be investigated. Our data suggest that type I
and II IFN modulation may represent an attractive treatment
target, as the teratogenicity of ZIKV may rely on latent vulner-
abilities of target cell types (NPCs), evading IFN-dependent
eradication in cells such as microglia and astrocytes that may
act as Trojan horses or even as viral reservoirs.
Materials and Methods
For a complete description of the materials and methods used in this paper,
please refer to SI Appendix. Virus stocks of DENV2 and ZIKVu were produced
in Vero and C6/36 cells. Microglia and neural progenitors were differenti-
ated from iPS cells and neural progenitors were used to generate astrocytes,
neurons, and neural organoids.
All experiments involving cells from human donors and animals were
performed in compliance with established IRB protocols at the Whitehead
institute.
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